Clinical Trial Update: Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating JSKN016 for advanced non-small cell lung cancer, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• JSKN016

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Advanced Non-small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING